Abubakar, Uting .

HRN: 27-76-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2025
CEFTAZIDIME 1GM (VIAL)
09/08/2025
09/14/2025
IV
1gm
Q8
CAP MR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines